IL10 and bronchiolitis obliterans syndrome: IL-10 gene therapy has been delivered using multiple vectors—such as adenovirus, lentivirus, and sendai virus—in chronic rejection models and has been shown to attenuate bronchiolitis obliterans (BO) following lung transplantation (70, 145, 146).